News

The partnership uses Evotec's phenotypic screening capabilities and compound libraries. According to the terms of the long-term drug discovery and development partnership, Celgene will pay an upfront payment of

The patents, among other aspects, broadly cover compositions of matter of the inflammation-targeting microfiber materials with embedded molecules of interest. The platform is being evaluated for use across

Juluca is a two-drug regimen of ViiV Healthcare’s dolutegravir and Janssen Sciences Ireland’s rilpivirine. The drug received approval to treat HIV-1 infection in adults, who are virologically suppressed (HIV-1

The clinical equivalence study is being conducted in 24 healthy subjects in a double-blind, randomised, parallel group protocol to evaluate the interchangeability between Q-Octreotide and the reference product,

The approval for the thrombopoietin (TPO) receptor agonist is for adult patients who are scheduled to go through a medical or dental procedure. The regulator said Doptelet is the

The company reported positive results from phase III Haven 3 study assessing Hemlibra prophylaxis administered every week or every two weeks in people with haemophilia A without factor

Hyperkalemia is a serious condition characterized by high levels of potassium in the blood (greater than 5.0 mEq/L). The risk of hyperkalemia increases significantly for patients with chronic

The newly established Seattle-based company's goal is to support GC Pharma's vaccine development activities. GC Pharma builds a strategic collaboration and partnership with global health organizations IDRI (Infectious

The late-stage trial named SPARTAN was held by the Johnson & Johnson (J&J) subsidiary in nmCRPC patients who had a rapidly increasing PSA while receiving continuous androgen deprivation